Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
148
Views
14
CrossRef citations to date
0
Altmetric
Review

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL

Matthew H Forsberg1 Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA, [email protected]
,
Amritava Das2 Wisconsin Institute for Discovery, University of Wisconsin, Madison, WI, USA, [email protected];3 Morgridge Institute for Research, University of Wisconsin, Madison, WI, USA
,
Krishanu Saha2 Wisconsin Institute for Discovery, University of Wisconsin, Madison, WI, USA, [email protected];4 Department of Medical History & Bioethics, University of Wisconsin, Madison, WI, USA, [email protected];5 Department of Biomedical Engineering, University of Wisconsin, Madison, WI, USA, [email protected]Correspondence[email protected]
&
Christian M Capitini1 Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA, [email protected];6 Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, USA, [email protected]Correspondence[email protected]
Pages 1573-1584 | Published online: 03 Sep 2018

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Varada Date & Sujit Nair. (2021) Emerging vistas in CAR T-cell therapy: challenges and opportunities in solid tumors. Expert Opinion on Biological Therapy 21:2, pages 145-160.
Read now
Marte Karen Brattås, Håkon Reikvam, Tor Henrik Anderson Tvedt & Øystein Bruserud. (2019) Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Expert Opinion on Investigational Drugs 28:5, pages 411-420.
Read now

Articles from other publishers (12)

Mohsen Sheykhhasan, Hamed Manoochehri & Paola Dama. (2022) Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study. Cancer Gene Therapy 29:8-9, pages 1080-1096.
Crossref
Paula Casano-Sancho & Ana Carolina Izurieta-Pacheco. (2022) Endocrine Late Effects in Childhood Cancer Survivors. Cancers 14:11, pages 2630.
Crossref
Jung Yoon Choi, Che Ry Hong, Kyung Taek Hong, Hyoung Jin Kang, Seongkoo Kim, Jae Wook Lee, Pil Sang Jang, Nack-Gyun Chung, Bin Cho, Hyery Kim, Kyung-Nam Koh, Ho Joon Im, Jong Jin Seo, Seung Min Hahn, Jung Woo Han, Chuhl Joo Lyu, Eu Jeen Yang, Young Tak Lim, Keon Hee Yoo, Hong Hoe Koo, Hoon Kook, In Sang Jeon, Hana Cho & Hee Young Shin. (2021) Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea. Cancer Research and Treatment 53:4, pages 1184-1194.
Crossref
Christine Ambrose, Lihe Su, Lan Wu, Fay J. Dufort, Thomas Sanford, Alyssa Birt, Benjamin J. Hackel, Andreas Hombach, Hinrich Abken, Roy R. Lobb & Paul D. Rennert. (2021) Anti-CD19 CAR T cells potently redirected to kill solid tumor cells. PLOS ONE 16:3, pages e0247701.
Crossref
Niraj Lodhi, Moe Tun, Poonam Nagpal, Arati A. Inamdar, Nehad M. Ayoub, Noor Siyam, Lucia Oton-Gonzalez, Angela Gerona, Dainelle Morris, Rana Sandhu & Kwangsun Stephen Suh. (2020) Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine. Oncotarget 11:44, pages 4045-4073.
Crossref
Frederick W. Thielen, Annemieke Dongen‐Leunis, Alexander M. M. Arons, Judith R. Ladestein, Peter M. Hoogerbrugge & Carin A. Uyl‐de Groot. (2020) Cost‐effectiveness of Anti‐CD19 chimeric antigen receptor T‐Cell therapy in pediatric relapsed/refractory B‐cell acute lymphoblastic leukemia. A societal view. European Journal of Haematology 105:2, pages 203-215.
Crossref
Mianzeng Yang, Bingcheng Liu, Ying Wang, Yuntao Liu, Xiaoyuan Gong, Benfa Gong, Yingxi Xu, Yingchang Mi, Min Wang & Jianxiang Wang. (2020) Chimeric antigen receptor-modified T-cell therapy for bone marrow and skin relapse Philadelphia chromosome-like acute lymphoblastic leukemia. Medicine 99:18, pages e18639.
Crossref
Alyssa Stoner, Jenna O. Miller, Terrie Flatt & Jessica S. Wallisch. (2020) Extracorporeal Membrane Oxygenation as a Bridge to Chimeric Antigen Receptor T-cell Therapy for Severe Refractory Sepsis in the Setting of Relapsed Refractory Pediatric Acute Lymphoblastic Leukemia: A Case Report. Critical Care Explorations 2:4, pages e0093.
Crossref
L. Herrera, S. Santos, M. A. Vesga, J. Anguita, I. Martin-Ruiz, T. Carrascosa, M. Juan & C. Eguizabal. (2019) Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells. Scientific Reports 9:1.
Crossref
Hugues Allard-Chamard. (2019) Laboratory Testing in the Context of Biologics and Cellular Therapies. Clinics in Laboratory Medicine 39:4, pages 657-668.
Crossref
Samia Asif, Rawish Fatima, Rebecca Krc, Joseph Bennett & Shahzad Raza. (2019) Comparative proteogenomic characterization of glioblastoma. CNS Oncology 8:2, pages CNS37.
Crossref
Uwe Fricke, Lutz Hein & Ulrich Schwabe. 2019. Arzneiverordnungs-Report 2019. Arzneiverordnungs-Report 2019 61 175 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.